Listed company MEI Pharma completes $100 million private placement, to be used for Litecoin strategic reserves

Odaily Planet Daily News: MEI Pharma announced the completion of a $100 million private placement, selling 29239767 ordinary shares or equivalent prepaid warrants at a price of $3.42 per share. The proceeds will be used to establish a Litecoin strategic reserve. The company also appointed Charlie Lee, the founder of Litecoin and the lead investor of this private placement, to the board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the execution of Litecoin's reserve strategy. （businesswire）